Injection site rotation: a simple system you will actually stick with

Why rotation matters more than people think

Subcutaneous injections are not free. Every pass of a needle through the skin and into the fat below leaves a small amount of tissue trauma, and some compounds — insulin most notoriously, but also other hormones — exert local effects on the adipose tissue around the injection bleb. Repeat that often enough in the same spot and the tissue changes. The fat pad becomes firmer, sometimes rubbery, sometimes visibly raised. That is lipohypertrophy: a benign but functionally important overgrowth of subcutaneous fat at injection sites. The opposite condition — lipoatrophy, a pitted loss of fat — is rarer with modern recombinant peptides but still possible.

The reason this matters for anyone tracking results is absorption. Lipohypertrophic tissue is poorly vascularized and unevenly perfused. Inject into it and the dose enters the bloodstream more slowly, less completely, and with much more variability than from healthy tissue. Blanco et al. (2013) studied 430 insulin users and found that 64.4% had lipohypertrophy, and that injection into a hypertrophic site was associated with worse glucose control, more frequent hypoglycemia, and higher daily insulin requirements compared with rotating into healthy tissue. The same principle applies to any subcutaneous peptide whose effect depends on consistent absorption — a long-acting GLP-1 agonist is just as dependent on plasma exposure as insulin.

In short: rotation is not cosmetic. It is the single biggest controllable variable in whether a dose does the same thing this week that it did last week.

The anatomy of a subcutaneous injection

The standard subcutaneous sites are the ones with enough loose fat to pinch a fold of at least a centimeter or two clear of muscle:

• Abdomen. Roughly a hand's width around the navel, avoiding the umbilical area itself and the rib margins. Generally the fastest absorption of the common sites.
• Outer thigh. The lateral aspect, roughly a hand's width below the hip and above the knee. Slower absorption than the abdomen.
• Upper outer arm / deltoid. The fleshy back of the upper arm. Limited surface area and harder to self-inject without an angled fold.
• Upper buttock / love handles. The flanks above the iliac crest, sometimes called the "love handles." Often the most underused real estate.

Absorption rate differences between these sites are well-documented for insulin: in classic pharmacokinetic studies, the abdomen produced the most rapid and most reproducible absorption, the arm intermediate, and the thigh and buttock slowest. Heinemann and colleagues (1994) further showed that other variables — subcutaneous fat thickness, local skin temperature, even how recently you exercised the limb — all change how fast a depot drains. For most modern long-acting peptides this matters less day to day, because the molecule's own half-life dominates the kinetics. But the principle still holds: if you alternate between the abdomen and the thigh week to week, you are introducing a small systematic source of variance you did not need to introduce.

The pragmatic implication is that it is fine to rotate within a region (one abdominal site this week, a different abdominal site next week), and it is also fine to rotate across regions as long as you are consistent. What you should not do is randomly pick a region each time and then wonder why a dose hits harder some weeks than others.

How far apart, and how often

The FITTER guidelines published by Frid and colleagues in 2016 — the most thoroughly cited international consensus on injection technique — recommend that successive injections within the same region be separated by at least 1 cm (some practitioner guides round this up to about 2.5 cm, or one inch, for simplicity). They also recommend leaving any single site untouched for a meaningful period before returning to it. The exact interval varies by source, but the practical floor is around one week per site.

A useful way to think about it: any site you have used in the last seven days is off limits, full stop. The tissue needs time to recover from the previous injection, and rotation only works if you actually let it work.

A 5-zone abdominal grid (the simplest workable system)

The abdomen is large enough, and well-vascularized enough, that many people can run an entire weekly rotation off it alone. Picture the abdomen as a 5x5 grid roughly 10 cm on a side, centered a few centimeters lateral to the navel on each side. That is more than 20 viable injection spots per side, far more than you will use in a year on a weekly GLP-1.

A simpler version that still works:

1. Upper right quadrant. Inject in week 1.
2. Lower right quadrant. Week 2.
3. Lower left quadrant. Week 3.
4. Upper left quadrant. Week 4.
5. Return to upper right — but shift the actual injection point at least 2.5 cm from where you went last time.

That single rule — never twice in the same square inch, ever — eliminates the most common rotation failure: same general area, same actual depot.

The "clock face" approach

A variant that works well for sites smaller than the abdomen (the outer thigh, the buttock):

• Picture the site as a clock face.
• Inject at 12 the first time, 3 the next, 6 the next, 9 the next.
• Each round, shift the center of the clock by an inch or two so successive cycles do not overlap.

The advantage is that it is easy to remember without looking anything up. The disadvantage is that it works for one site only; if you want to rotate across regions, you need a higher-level system on top of it.

Daily, weekly, and intramuscular special cases

The right rotation system depends on dosing frequency.

• Low-volume daily injections — for example, GH secretagogues like ipamorelin or CJC-1295 (no DAC), often dosed 5–7 days per week at 0.1–0.2 mL per shot. Daily injections give the tissue less recovery time per site, so the spacing rule does most of the work. A 7-day rotation across 5 abdominal squares plus 2 thigh squares is more than enough.
• Weekly larger-volume injections — GLP-1 agonists like semaglutide and tirzepatide, typical injection volume 0.25–0.5 mL. The depot is bigger and the local tissue effect is larger, so a strict no-repeat-within-a-week rule combined with quadrant rotation is sufficient. The FDA labels for Wegovy and Mounjaro both explicitly direct patients to rotate sites with every dose.
• Intramuscular injections — some peptides (HCG, Cerebrolysin) are conventionally given IM rather than subq. These sites are entirely different (gluteus, ventrogluteal, deltoid) and the recovery interval is longer because muscle tissue heals more slowly than fat. A 2-week minimum between any two injections in the same muscle is a reasonable default.

How to spot lipohypertrophy before it spots you

The early signs are tactile, not visual. By the time a hypertrophic site is visibly raised, it is well-established. The right way to check, drawn from the FITTER protocol, is:

1. Stand in front of a mirror in good light.
2. Slowly run your fingertips across every site you use. Press gently and feel for differences in firmness, springiness, or temperature relative to the surrounding tissue.
3. Pay special attention to your most frequently used sites — your favorite spots are where this almost always shows up first.
4. Compare side to side. The corresponding spot on the opposite side of your body is your control.

A hypertrophic patch feels like a small rubber pad just under the skin. It may not hurt at all, which is part of the problem — these spots are often less sensitive to needle pain than healthy tissue, which makes them easier to keep using and harder to notice.

If you find one, the only treatment is avoidance. Stop using that site entirely. Tissue remodels slowly: most published series report partial resolution over 3–6 months and full resolution over 6–12 months of consistent avoidance. Massage and warm compresses are sometimes recommended but the evidence is weak; not injecting there is what actually fixes it.

Building a rotation you will actually follow

The hardest part of rotation is not the geometry — it is remembering what you did last time. A few systems work:

• The post-it diary. Sticky note on the fridge or in the bathroom: a body diagram with a dot per injection. Crude but effective for people who like analog tools.
• The calendar method. Every dose entry on a paper or digital calendar gets the site name appended. "Tue — 0.5 mg semaglutide — R upper abdomen." Searchable, durable.
• The phone log. Notes app or a dedicated injection tracker. The advantage of a dedicated tracker is visualization — a body map that shows the last 30 days at a glance, so you can see at a moment that you have been favoring your left side and need to switch.
• Pure rote. Some people just memorize a sequence (UR abdomen → LR → LL → UL → R thigh → L thigh) and never deviate. Works as long as you actually do not deviate.

Whatever system you use, the rule is the same: the decision must be made before you draw up the dose, not while the needle is already in your hand. The decision points that get made under time pressure are the ones that get fudged.

What to do if you have been rotating poorly for months

This is a common situation: someone realizes after the fact that they have been injecting into roughly the same square inch for the last six months and is now wondering whether the tissue is permanently changed. A few practical steps:

• Palpate every region first. Establish where the damage is.
• Stop using affected sites entirely. Plan a rotation off the unaffected real estate. The abdomen alone has dozens of viable sites; if half of it is off-limits, the other half plus thighs and flanks is more than enough.
• Expect dose response to shift. As you move into healthy tissue, absorption may increase — especially with insulin, where this can produce unexpected hypoglycemia. The same principle applies to any compound where you have unknowingly been delivering a smaller-than-intended effective dose. Track effects carefully for the first few weeks after a major rotation reset.
• Give it time. Months, not weeks, before the affected tissue normalizes.

What Vial automates

The site rotation feature in Vial keeps a heat map of every injection you log. Each region carries a "days since last used" indicator, and when you go to record a dose, the app surfaces the freshest available site automatically. You can override it, but the default is always the spot you have rested the longest. The visualization also flags clustering — if a particular square has crept up over the last month, it shows in red. The system is not magic, and it does not replace palpation, but it removes the one piece of friction (remembering what you did three weeks ago) that causes most rotation plans to fail.